Company Announcement US & EU Patent Allowances for CBD Soft-Gel Formulation December 3, 2025December 3, 2025
Company Announcement Research report | RaaS Watchlist: Waking the Sleeping Giant August 26, 2025August 26, 2025
Company Announcement New Sites Commence Recruitment For Phase III Clinical Trial May 20, 2025May 21, 2025
Company Announcement Avecho receives US$3M upfront payment from Sandoz AG March 28, 2025March 28, 2025
Company Announcement Avecho and Sandoz enter exclusive license and development agreement to commercialise CBD for insomnia in Australia March 3, 2025March 3, 2025
